Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Miller, Christopher A ^a   Settle, Stephen H ^a,b   Sulman, Erik P ^b   Aldape, Kenneth D ^b   Milosavljevic, Aleksandar ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; EP300 PROTEIN, HUMAN;

ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; COPY NUMBER VARIATION; GENETIC ALGORITHM; GLIOBLASTOMA; HUMAN; INTERMETHOD COMPARISON; MUTATIONAL ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; VALIDATION PROCESS; COMPUTER SIMULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN GENOME; MUTATION; NEOPLASM; SIGNAL TRANSDUCTION; SURVIVAL;

COMPUTER SIMULATION; E1A-ASSOCIATED P300 PROTEIN; GENE REGULATORY NETWORKS; GENOME, HUMAN; GLIOBLASTOMA; HUMANS; MUTATION; NEOPLASMS; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS;

EID: 79953902594     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-34     Document Type: Article

References (30)

1. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Cancer Genome Atlas Consortium, Nature 2008 455 1061 1068 10.1038/nature07385 18772890
2. Cluster analysis and display of genome-wide expression patterns. MB Eisen PT Spellman PO Brown D Botstein, Proceedings of the National Academy of Sciences of the United States of America 1998 95 14863 14868 10.1073/pnas.95.25.14863 9843981 (Pubitemid 29003722)
3. Reverse engineering of regulatory networks in human B cells. K Basso AA Margolin G Stolovitzky U Klein R Dalla-Favera A Califano, Nat Genet 2005 37 382 390 10.1038/ng1532 15778709
4. A module map showing conditional activity of expression modules in cancer. E Segal N Friedman D Koller A Regev, Nat Genet 2004 36 1090 1098 10.1038/ng1434 15448693 (Pubitemid 41184471)
5. Gene expression alterations over large chromosomal regions in cancers include multiple genes unrelated to malignant progression. BG Masayesva P Ha E Garrett-Mayer T Pilkington R Mao J Pevsner T Speed N Benoit C Moon D Sidransky WH Westra J Califano, Proceedings of the National Academy of Sciences of the United States of America 2004 101 8715 8720 10.1073/pnas.0400027101 15155901 (Pubitemid 38745837)
6. Microarray reality checks in the context of a complex disease. GLG Miklos R Maleszka, Nat Biotechnol 2004 22 615 621 10.1038/nbt965 15122300 (Pubitemid 38585915)
7. Global Mapping of the Yeast Genetic Interaction Network. AHY Tong G Lesage GD Bader H Ding H Xu X Xin J Young GF Berriz RL Brost M Chang Y Chen X Cheng G Chua H Friesen DS Goldberg J Haynes C Humphries G He S Hussein L Ke N Krogan Z Li JN Levinson H Lu P Menard C Munyana AB Parsons O Ryan R Tonikian T Roberts A Sdicu J Shapiro B Sheikh B Suter SL Wong LV Zhang H Zhu CG Burd S Munro C Sander J Rine J Greenblatt M Peter A Bretscher G Bell FP Roth GW Brown B Andrews H Bussey C Boone, Science 2004 303 808 813 10.1126/science.1091317 14764870 (Pubitemid 38174652)
8. Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers? AF Gazdar H Shigematsu J Herz JD Minna, Trends Mol Med 2004 10 481 486 10.1016/j.molmed.2004.08.008 15464447 (Pubitemid 39303620)
9. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer. SA Tomlins DR Rhodes S Perner SM Dhanasekaran R Mehra X Sun S Varambally X Cao J Tchinda R Kuefer C Lee JE Montie RB Shah KJ Pienta MA Rubin AM Chinnaiyan, Science 2005 310 644 648 10.1126/science.1117679 16254181 (Pubitemid 41528150)
10. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. J Momand GP Zambetti DC Olson D George AJ Levine, Cell 1992 69 1237 1245 10.1016/0092-8674(92)90644-R 1535557
11. Combinatorial patterns of somatic gene mutations in cancer. C Yeang F McCormick A Levine, FASEB J 2008 22 2605 2622 10.1096/fj.08-108985 18434431
12. Introduction to Probability Models, Seventh Edition. SM Ross, Academic Press 7 2000
13. Circular binary segmentation for the analysis of array-based DNA copy number data. AB Olshen ES Venkatraman R Lucito M Wigler, Biostatistics 2004 5 557 572 10.1093/biostatistics/kxh008 15475419 (Pubitemid 41180205)
14. Functional Copy-Number Alterations in Cancer. BS Taylor J Barretina ND Socci P DeCarolis M Ladanyi M Meyerson S Singer C Sander, PLoS ONE 2008 3 3179 10.1371/journal.pone.0003179 18784837
15. Learning Quickly When Irrelevant Attributes Abound: A New Linear-Threshold Algorithm. N Littlestone, Mach. Learn 1988 2 285 318
16. Discovering simple DNA sequences by the algorithmic significance method. A Milosavljevic J Jurka, Comput Appl Biosci 1993 9 4 407 411 8402207 (Pubitemid 23233966)
17. Using markov models and hidden markov models to find repetitive extragenic palindromic sequences in Escherichia Coli. K Karplus, Technical Report UCSC-CRL-94-24 1994
18. Statistical significance in biological sequence analysis. AY Mitrophanov M Borodovsky, Brief Bioinform 2006 7 2 24 10.1093/bib/bbk001 16761361 (Pubitemid 44404320)
19. A Probabilistic Model of Local Sequence Alignment That Simplifies Statistical Significance Estimation. SR Eddy, PLoS Comput Biol 2008 4 1000069 10.1371/journal.pcbi.1000069 18516236
20. Textual data compression in computational biology: a synopsis. R Giancarlo D Scaturro F Utro, Bioinformatics 2009 25 1575 1586 10.1093/bioinformatics/btp117 19251772
21. Discovering Dependencies via Algorithmic Mutual Information: A Case Study in DNA Sequence Comparisons. A Milosavljevic, Mach. Learn 1995 21 35 50
22. Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology. LA Gravendeel MC Kouwenhoven O Gevaert JJ de Rooi AP Stubbs JE Duijm A Daemen FE Bleeker LB Bralten NK Kloosterhof B De Moor PH Eilers PJ van der Spek JM Kros PA Sillevis Smitt MJ van den Bent PJ French, Cancer Res 2009 69 9065 9072 10.1158/0008-5472.CAN-09-2307 19920198
23. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. M Dai P Wang AD Boyd G Kostov B Athey EG Jones WE Bunney RM Myers TP Speed H Akil SJ Watson F Meng, Nucleic Acids Res 2005 33 175 e175 10.1093/nar/gni179 16284200
24. Nonparametric estimation from incomplete observations. EL Kaplan P Meier, J.of the American Statistical Association 1958 53 457 48 10.2307/2281868
25. Regression models and life tables. DR Cox, J Royal Stat Soc 1972 34 187 220
26. p53, the cellular gatekeeper for growth and division. AJ Levine, Cell 1997 88 323 331 10.1016/S0092-8674(00)81871-1 9039259 (Pubitemid 27131374)
27. DNA-dependent acetylation of p53 by the transcription coactivator p300. D Dornan H Shimizu ND Perkins TR Hupp, J. Biol. Chem 2003 278 13431 13441 10.1074/jbc.M211460200 12499368 (Pubitemid 36800117)
28. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. R Goldman RB Levy E Peles Y Yarden, Biochemistry 1990 29 11024 11028 10.1021/bi00502a002 1980216
29. Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. H Kim W Huang X Jiang B Pennicooke PJ Park MD Johnson, Proceedings of the National Academy of Sciences 2010 107 2183 2188 10.1073/pnas.0909896107
30. Beyond Grade: Molecular Pathology of Malignant Gliomas. EP Sulman M Guerrero K Aldape, Seminars in Radiation Oncology 2009 19 142 149 10.1016/j.semradonc.2009.02.001 19464628